Globus Medical (GMED) Tops Q3 EPS by 5c

Globus Medical (NYSE: GMED) reported Q3 EPS of $0.50, $0.05 better than the analyst estimate of $0.45. Revenue for the quarter came in at $229.7 million versus the consensus estimate of $228.31 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• Ross Stores raises 2026 outlook after strong second-quarter results